[Mechanism of antisense epidermal growth factor receptor cDNA in growth suppression of glioblastomas cells]
Related Experiment Video
Updated: Aug 8, 2026

A Simple Guide Screw Method for Intracranial Xenograft Studies in Mice
Published on: September 26, 2011
Xin-xia Tian1, Ho-keung Ng, Chung-sean Pang
1Department of Pathology, Health Science Center, Peking University, Beijing 100083, China. tianxinxia@yahoo.com
Objective:
To study the mechanism of antisense epidermal growth factor receptor cDNA in growth suppression of glioblastomas cells.
Methods:
Glioblastoma U87MG cells, which over-express epidermal growth factor receptor (EGFR), were transfected with antisense-EGFR constructs. Several clones with stable expression of lower or undetectable levels of EGFR protein were obtained. The effect of antisense-EGFR on cell differentiation was studied using morphological evaluation and western blotting analysis of glial fibrillary acidic protein (GFAP) expression. The effect of antisense-EGFR on cell cycle was studied by flow cytometry and immunohistochemical analysis of p53, Rb, p16 and CDK4 expressions. The effect of antisense-EGFR on telomerase activity was studied by telomeric repeat amplification protocol (TRAP) assay.
Results:
U87MG cells that were transfected with antisense-EGFR constructs had smaller cell bodies and longer processes, and expressed higher level of GFAP compared with that of the control cells. Flow cytometric analysis showed that the proportion of cells in G(0)/G(1) phases of the cell cycle in the antisense EGFR cDNA transfected clones increased significantly when compared with control cells, whereas the proportion of cells in S phase decreased markedly. In addition, immunohistochemical analysis showed that the expression of wild-type p53 was significantly increased in the antisense-EGFR cDNA transfected clones, whereas the expressions of Rb, p16 and CDK4 were not altered. TRAP assay revealed that telomerase activity in the antisense-EGFR clones was significantly decreased.
Conclusions:
Antisense-EGFR transfection inhibits U87MG cell growth by inducing cell differentiation and p53 expression, G(1) cell cycle arrest and inhibition of telomerase activity.
Insights
Antisense epidermal growth factor receptor (EGFR) cDNA inhibits glioblastoma cell growth by promoting differentiation, increasing p53 expression, arresting the cell cycle, and reducing telomerase activity.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Cell Biology
Background:
- Glioblastoma is an aggressive brain tumor characterized by overexpression of the epidermal growth factor receptor (EGFR).
- Targeting EGFR is a key strategy in glioblastoma treatment.
- Understanding the precise mechanisms of EGFR inhibition is crucial for developing effective therapies.
Purpose of the Study:
- To elucidate the mechanism by which antisense epidermal growth factor receptor (EGFR) cDNA suppresses glioblastoma cell growth.
- To investigate the effects of antisense EGFR on cell differentiation, cell cycle progression, and telomerase activity in U87MG cells.
Main Methods:
- Transfection of U87MG glioblastoma cells with antisense EGFR constructs.
- Assessment of EGFR protein levels, cell morphology, and glial fibrillary acidic protein (GFAP) expression for differentiation.
- Flow cytometry and immunohistochemistry to analyze cell cycle distribution and key protein expressions (p53, Rb, p16, CDK4).
- Telomeric repeat amplification protocol (TRAP) assay to measure telomerase activity.
Main Results:
- Antisense EGFR transfection led to morphological changes indicative of differentiation (smaller cell bodies, longer processes) and increased GFAP expression.
- Significant G(0)/G(1) phase arrest and decreased S phase proportion were observed in transfected cells.
- Wild-type p53 expression was significantly upregulated, while Rb, p16, and CDK4 expressions remained unchanged.
- Telomerase activity was significantly inhibited in antisense EGFR clones.
Conclusions:
- Antisense EGFR cDNA effectively inhibits U87MG glioblastoma cell growth.
- The growth inhibition is mediated through induction of cell differentiation and p53 expression.
- Cell cycle arrest at the G(1) phase and reduced telomerase activity are key mechanisms involved.
More Related Videos
Related Concept Videos
Experimental RNAi
Mitogens and the Cell Cycle
Abnormal Proliferation

